As of 2026-03-20, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 48.63 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -58.2%.
The range of the Relative Valuation is 35.77 - 57.35 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 26.8x | 23.5x |
| Forward P/E multiples | 16.3x - 24.9x | 22.8x |
| Fair Price | 35.77 - 57.35 | 48.63 |
| Upside | -69.2% - -50.7% | -58.2% |
| Date | P/E |